JNJ vs DVA
By Alex · Tickerpine
Johnson & Johnson vs DaVita Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | DVA |
|---|---|---|
| Price | $271.95 | $178.07 |
| Market cap | $655.37B | $11.36B |
| P/E ratio | 31.4 | 15.1 |
| ROE | 25.74% | 88.48% |
| Profit margin | 21.48% | 6.05% |
| Revenue growth | 6.60% | 5.20% |
| Dividend yield | 1.97% | — |
| Beta | 0.23 | 0.83 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs DVA in plain English
- JNJ is the bigger company — about 57.7× the market cap of DVA.
- DVA is cheaper on earnings (P/E 15.1 vs 31.4).
- DVA earns a higher return on equity (88% vs 26%).
- JNJ is growing revenue faster (7% vs 5%).
- JNJ pays a dividend (1.97%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
DVA return calculator
See what $1,000 in DaVita Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.